Analysts predict that Surgery Partners Inc (NASDAQ:SGRY) will report earnings of ($0.08) per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Surgery Partners’ earnings. The highest EPS estimate is $0.01 and the lowest is ($0.17). Surgery Partners reported earnings per share of ($0.02) in the same quarter last year, which would suggest a negative year-over-year growth rate of 300%. The company is expected to issue its next earnings report on Wednesday, November 14th.

On average, analysts expect that Surgery Partners will report full-year earnings of ($0.20) per share for the current financial year, with EPS estimates ranging from ($0.27) to ($0.11). For the next financial year, analysts anticipate that the firm will report earnings of $0.21 per share, with EPS estimates ranging from ($0.09) to $0.47. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Thursday, August 9th. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.07. The company had revenue of $444.78 million for the quarter, compared to the consensus estimate of $428.50 million. Surgery Partners had a negative return on equity of 1.67% and a negative net margin of 5.56%. The firm’s quarterly revenue was up 54.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.09) EPS.

Several analysts recently weighed in on the company. Leerink Swann upped their price target on Surgery Partners from $20.00 to $25.00 and gave the stock an “outperform” rating in a research note on Monday. BidaskClub upgraded Surgery Partners from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 16th. Zacks Investment Research upgraded Surgery Partners from a “hold” rating to a “buy” rating and set a $20.00 price target on the stock in a research note on Thursday. ValuEngine upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, June 21st. Finally, Royal Bank of Canada upped their price target on Surgery Partners from $18.00 to $20.00 and gave the stock an “outperform” rating in a research note on Friday, August 10th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $19.43.

Shares of Surgery Partners stock traded down $0.20 during midday trading on Friday, hitting $17.30. The company had a trading volume of 333,054 shares, compared to its average volume of 333,461. The company has a quick ratio of 1.44, a current ratio of 1.59 and a debt-to-equity ratio of 1.69. The company has a market capitalization of $870.46 million, a P/E ratio of -20.83 and a beta of 1.78. Surgery Partners has a 52-week low of $7.10 and a 52-week high of $19.95.

Hedge funds have recently added to or reduced their stakes in the stock. US Bancorp DE lifted its position in Surgery Partners by 76.6% in the 2nd quarter. US Bancorp DE now owns 7,328 shares of the company’s stock valued at $109,000 after acquiring an additional 3,179 shares in the last quarter. MetLife Investment Advisors LLC bought a new position in Surgery Partners in the 1st quarter valued at approximately $164,000. Bank of Montreal Can bought a new position in Surgery Partners in the 2nd quarter valued at approximately $149,000. Raymond James & Associates bought a new position in Surgery Partners in the 2nd quarter valued at approximately $185,000. Finally, GSA Capital Partners LLP bought a new position in Surgery Partners in the 1st quarter valued at approximately $222,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Read More: Fundamental Analysis – How It Helps Investors

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.